EPRX
Price
$5.44
Change
-$0.03 (-0.55%)
Updated
Oct 27, 11:22 AM (EDT)
Capitalization
276.7M
9 days until earnings call
Intraday Buy/Sell Signals
LEXX
Price
$1.04
Change
+$0.11 (+11.83%)
Updated
Oct 27, 11:33 AM (EDT)
Capitalization
20.64M
2 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

EPRX vs LEXX

Header iconEPRX vs LEXX Comparison
Open Charts EPRX vs LEXXBanner chart's image
Eupraxia Pharmaceuticals
Price$5.44
Change-$0.03 (-0.55%)
Volume$1.81K
Capitalization276.7M
Lexaria Bioscience
Price$1.04
Change+$0.11 (+11.83%)
Volume$2.3K
Capitalization20.64M
EPRX vs LEXX Comparison Chart in %
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LEXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EPRX vs. LEXX commentary
Oct 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPRX is a Hold and LEXX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 27, 2025
Stock price -- (EPRX: $5.47 vs. LEXX: $0.93)
Brand notoriety: EPRX and LEXX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EPRX: 52% vs. LEXX: 17%
Market capitalization -- EPRX: $276.7M vs. LEXX: $20.64M
EPRX [@Biotechnology] is valued at $276.7M. LEXX’s [@Biotechnology] market capitalization is $20.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $108.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EPRX’s FA Score shows that 0 FA rating(s) are green whileLEXX’s FA Score has 0 green FA rating(s).

  • EPRX’s FA Score: 0 green, 5 red.
  • LEXX’s FA Score: 0 green, 5 red.
According to our system of comparison, both EPRX and LEXX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EPRX’s TA Score shows that 5 TA indicator(s) are bullish while LEXX’s TA Score has 4 bullish TA indicator(s).

  • EPRX’s TA Score: 5 bullish, 5 bearish.
  • LEXX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, EPRX is a better buy in the short-term than LEXX.

Price Growth

EPRX (@Biotechnology) experienced а -5.36% price change this week, while LEXX (@Biotechnology) price change was +11.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.61%. For the same industry, the average monthly price growth was +11.19%, and the average quarterly price growth was +64.92%.

Reported Earning Dates

EPRX is expected to report earnings on Nov 05, 2025.

LEXX is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (-0.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EPRX($277M) has a higher market cap than LEXX($20.6M). EPRX YTD gains are higher at: 72.555 vs. LEXX (-55.781). LEXX has higher annual earnings (EBITDA): -11.31M vs. EPRX (-28.83M). EPRX has more cash in the bank: 19.8M vs. LEXX (4.63M). EPRX has less debt than LEXX: EPRX (35.1K) vs LEXX (117K). LEXX has higher revenues than EPRX: LEXX (616K) vs EPRX (0).
EPRXLEXXEPRX / LEXX
Capitalization277M20.6M1,345%
EBITDA-28.83M-11.31M255%
Gain YTD72.555-55.781-130%
P/E RatioN/AN/A-
Revenue0616K-
Total Cash19.8M4.63M428%
Total Debt35.1K117K30%
FUNDAMENTALS RATINGS
LEXX: Fundamental Ratings
LEXX
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EPRXLEXX
RSI
ODDS (%)
Bearish Trend 5 days ago
68%
Bearish Trend 4 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
85%
Momentum
ODDS (%)
Bearish Trend 4 days ago
71%
Bullish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
74%
Bullish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
65%
Bullish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
56%
Bearish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 19 days ago
81%
Bullish Trend 8 days ago
87%
Declines
ODDS (%)
Bearish Trend 11 days ago
72%
Bearish Trend 13 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
74%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LEXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PAHGF3.250.07
+2.20%
Pets at Home Group PLC
DIMC41.250.74
+1.83%
Dimeco, Inc.
PINXF0.97N/A
N/A
Peoples Insurance Company Group China
SEOJF8.56N/A
N/A
Stora Enso Oyj
REVFF0.16N/A
N/A
REV Explorations Corp.

EPRX and

Correlation & Price change

A.I.dvisor tells us that EPRX and NAGE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EPRX and NAGE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPRX
1D Price
Change %
EPRX100%
-3.70%
NAGE - EPRX
32%
Poorly correlated
+2.02%
ETNB - EPRX
29%
Poorly correlated
-0.07%
ACAD - EPRX
28%
Poorly correlated
+1.33%
IOVA - EPRX
26%
Poorly correlated
+2.74%
XTLB - EPRX
25%
Poorly correlated
-0.81%
More

LEXX and

Correlation & Price change

A.I.dvisor tells us that LEXX and PDSB have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LEXX and PDSB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LEXX
1D Price
Change %
LEXX100%
+2.04%
PDSB - LEXX
30%
Poorly correlated
-0.02%
PEPG - LEXX
29%
Poorly correlated
+1.56%
MIST - LEXX
28%
Poorly correlated
-0.53%
BTAI - LEXX
27%
Poorly correlated
+3.10%
EPRX - LEXX
27%
Poorly correlated
-3.70%
More